dextroamphetamine has been researched along with Hearing Loss, Sensorineural in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tobey, EA | 1 |
| Devous, MD | 1 |
| Buckley, K | 1 |
| Overson, G | 1 |
| Harris, T | 1 |
| Ringe, W | 1 |
| Martinez-Verhoff, J | 1 |
1 trial available for dextroamphetamine and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Pharmacological enhancement of aural habilitation in adult cochlear implant users.
Topics: Adult; Aged; Auditory Cortex; Central Nervous System Stimulants; Cerebrovascular Circulation; Cochle | 2005 |